SHANGHAI KAIBAO
3000395.501.66% ( +0.09 )
SHANGHAI KAIBAO (300039)
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. Th...
- Open
- 5.36
- High
- 5.59
- Low
- 5.35
- Prev. Close
- 5.41
- Volume
- 489.73K
- Turnover
- 268.93M
- Avg Price
- 5.49
- Bid/Ask Ratio
- --
- Amplitude
- 4.44%
- 52wk High
- 6.90
- Volume Ratio
- 0.55
- Turnover Ratio
- 4.68%
SHANGHAI KAIBAO Analyst Rating
View MoreForecast & Rating
May 11, 2018Price forecast
--100.00%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 28, 2025 at 06:52 AM
SHANGHAI KAIBAO: Net profit for the third quarter was 65.0877 million yuan, a decrease of 13.13%
- Zhitong · Aug 27, 2025 at 07:27 AM
SHANGHAI KAIBAO released its performance for the first half of the year, with a net profit attributable to the parent company of 122 million yuan, a decrease of 14.20%
- Zhitong · Jul 16, 2025 at 06:15 AM
SHANGHAI KAIBAO plans to sell no more than 6.2011 million shares of SHANGHAI YIZHONG at an opportune time
- Zhitong · Jul 1, 2025 at 09:20 AM
The concerted action party of the actual controller of SHANGHAI KAIBAO, Kaiyi Trading, plans to reduce its holdings by no more than 1%
- Zhitong · Jul 1, 2025 at 03:11 AM
SHANGHAI KAIBAO has obtained the drug registration certificate for Phlegm-Heat Clearing Capsules
- Zhitong · Apr 16, 2025 at 02:09 AM
SHANGHAI KAIBAO and others invest to establish a technology company, including Internet of Things-related businesses
